201 related articles for article (PubMed ID: 24853985)
21. Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.
Gonçalves FQ; Pires J; Pliassova A; Beleza R; Lemos C; Marques JM; Rodrigues RJ; Canas PM; Köfalvi A; Cunha RA; Rial D
Eur J Neurosci; 2015 Apr; 41(7):878-88. PubMed ID: 25704806
[TBL] [Abstract][Full Text] [Related]
22. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.
Nayak S; Khan MA; Wan TC; Pei H; Linden J; Dwinell MR; Geurts AM; Imig JD; Auchampach JA
Purinergic Signal; 2015 Dec; 11(4):519-31. PubMed ID: 26385692
[TBL] [Abstract][Full Text] [Related]
24. The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A
Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Colotta V
Eur J Med Chem; 2018 Apr; 150():127-139. PubMed ID: 29525433
[TBL] [Abstract][Full Text] [Related]
25. Agonists activate different A
Koussémou M; Klotz KN
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1515-1521. PubMed ID: 31338535
[TBL] [Abstract][Full Text] [Related]
26. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
27. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.
Varani K; Caramori G; Vincenzi F; Tosi A; Barczyk A; Contoli M; Casolari P; Triggiani M; Hansel T; Leung E; Maclennan S; Barnes PJ; Chung KF; Adcock I; Papi A; Borea PA
FASEB J; 2010 Apr; 24(4):1192-204. PubMed ID: 20008542
[TBL] [Abstract][Full Text] [Related]
28. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
29. The inhibition of human lung fibroblast proliferation and differentiation by Gs-coupled receptors is not predicted by the magnitude of cAMP response.
Roberts MJ; Broome RE; Kent TC; Charlton SJ; Rosethorne EM
Respir Res; 2018 Apr; 19(1):56. PubMed ID: 29625570
[TBL] [Abstract][Full Text] [Related]
30. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
[TBL] [Abstract][Full Text] [Related]
31. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
32. Activation of adenosine A
Carlin JL; Jain S; Duroux R; Suresh RR; Xiao C; Auchampach JA; Jacobson KA; Gavrilova O; Reitman ML
Neuropharmacology; 2018 Sep; 139():268-278. PubMed ID: 29548686
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of the A
Dierks A; Bader A; Lehrich T; Ngezahayo A
Cell Physiol Biochem; 2019; 53(4):606-622. PubMed ID: 31550088
[TBL] [Abstract][Full Text] [Related]
34. Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells.
Cagnina RE; Ramos SI; Marshall MA; Wang G; Frazier CR; Linden J
Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L467-74. PubMed ID: 19574419
[TBL] [Abstract][Full Text] [Related]
35. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
[TBL] [Abstract][Full Text] [Related]
36. Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors.
Brulé C; Perzo N; Joubert JE; Sainsily X; Leduc R; Castel H; Prézeau L
FASEB J; 2014 Dec; 28(12):5148-62. PubMed ID: 25183668
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
38. Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation.
Hua X; Chason KD; Jania C; Acosta T; Ledent C; Tilley SL
J Pharmacol Exp Ther; 2013 Feb; 344(2):426-35. PubMed ID: 23149337
[TBL] [Abstract][Full Text] [Related]
39. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
[TBL] [Abstract][Full Text] [Related]
40.
Hamed O; Joshi R; Michi AN; Kooi C; Giembycz MA
Mol Pharmacol; 2021 Oct; 100(4):388-405. PubMed ID: 34341099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
